The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

An unusual swelling in the legs and feet could indicate the onset of kidney damage. When the kidneys struggle to eliminate ...

Lithium is associated with an increased risk for thyroid dysfunction and chronic kidney disease (CKD) in patients with ...

Our study thus confirmed what was found in people of African descent in the US: the genetic origin underpinning the excess ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.

A well-known class of drugs used to manage type 2 diabetes and control weight could offer hope for patients who also struggle ...

The future of healthcare is defined by this blend of technology and human expertise, offering new hope for a more efficient ...

Study led by Mount Sinai researcher shows sotagliflozin is the only drug in its class to demonstrate these results ...

In a powerful act of love and sacrifice, Julie Malliet donated her kidney to her husband, Dave, who had been battling chronic kidney disease for years.

When Mrs Jennie Tan was diagnosed with end-stage kidney disease, her husband made a decision that gave her a second chance at ...